To include your compound in the COVID-19 Resource Center, submit it here.

Retaspimycin: Phase Ib/II started

Infinity began a dose-escalation, U.S. Phase Ib/II trial to evaluate 450 mg/m 2 IV retaspimycin weekly in

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE